Article Index

Merck, Pfizer Earnings Send Shares in Opposite Directions (NYSE: PFE) (NYSE: MRK)

news today

The Pfizer earnings and Merck earnings reports were both released this morning (Tuesday), and investors are acting differently to these major pharmaceutical stocks.

Pfizer Inc. (NYSE: PFE) stock was up 1.3% in early trading despite missing earnings per share estimates. Merck shares were down 2% despite topping estimates.

Here's why the stocks are behaving so differently...

This New Alzheimer's Drug Could Be the Fastest Route to a Treatment Breakthrough

new Alzheimer’s drug

Just last week, two major pharmaceutical companies announced that they are working together on a new Alzheimer's drug - and that's great news. But it may be a decade away from becoming reality.

But another biotech company is zooming ahead in the race for the cure - and its drug is in late-stage phase 3 trials.

In other words, there is a way to both fight Alzheimer’s and supercharge your portfolio – today…

This Cutting-Edge Drug Has Endocyte (Nasdaq: ECYT) Stock Soaring

nasdaq: ecyt

Endocyte Inc. (Nasdaq: ECYT) stock skyrocketed over 130% today (Friday) after the Indiana-based biopharma won market approval for its first drug, a cancer therapeutic called "vintafolide." The drug was developed in collaboration with Merck & Co. (NYSE: MRK).

Today, Merck announced the European Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion of vintafolide, along with its companion imaging agent, etarfolatide. The drugs were part of a group CHMP voted to approve during a March 17-20 meeting.

To continue reading, please click here...

Market News: Dow Jones Industrial Average Falls for Fifth Straight Session

Stock Market News Today, Jan. 27: U.S. stocks are compounding last week's selloff, with all three major indices dropping into the red as home sales fell 7% in December.

The Dow Jones Industrial Average fell 41.23 points, or 0.3%, to 15,837.75; the S&P 500 fell 0.5%, or 8.73 points, to 1,781.56; and the Nasdaq fell 1.1%, or 44.56 points, to 4,083.61.

To continue reading, please click here...

Activist Investors Will Be Targeting More Stocks - Meaning Higher Share Prices Ahead

Conditions just happen to be ideal right now for activist investing. That means a lot of stocks will be targeted - and a lot of share prices will get a jolt. You can get a piece of those gains for yourself, but you have to beat the likes of Carl Icahn to the punch. And the only way to do that is to identify potential targets before they do.

Here's how...

Stock Market News Today: Big Day for Apple (Nasdaq: AAPL), Merck (NYSE: MRK)

Stock Market News Today, Oct. 28: Stocks are weighed in morning trade, reversing out of earlier gains as investors are hit with a disappointing report on pending home sales despite a more positive report on industrial production.

Pending home sales slid 5.6% in September to the lowest level in nine months, likely weighed by higher housing prices and higher interest rates.

To continue reading, please click here...

How to Invest in Agriculture After the Potash Price Crash

Global commodity woes increased again on Tuesday after Russia's Uralkali broke up one of the world's largest potash partnerships and ended a marketing venture agreement with producers in Belarus.

This development changes how to invest in agriculture- as it has already sent investors fleeing from nutrient and fertilizer stocks this week.

In addition, the impact will likely crash global potash prices by 25% to 30%, as the collapse of an international duopoly will end a price-fixing agreement that benefited other producers of the key commodity by artificially inflating prices and keeping supply off the market.

To continue reading, please click here...